Literature DB >> 7650192

Direct determination of cryptococcal antigen in transthoracic needle aspirate for diagnosis of pulmonary cryptococcosis.

Y S Liaw1, P C Yang, C J Yu, D B Chang, H J Wang, L N Lee, S H Kuo, K T Luh.   

Abstract

Pulmonary cryptococcosis causes significant morbidity and mortality in immunocompromised patients. Definitive diagnosis of pulmonary cryptococcosis is usually difficult. The use of direct determination of cryptococcal antigen in transthoracic needle aspirate to diagnose pulmonary cryptococcosis was investigated. Over a 2-year period, we studied a total of 41 patients with respiratory symptoms and pulmonary infiltrates of unknown etiology who were suspected of having pulmonary cryptococcosis. Twenty-two patients were immunocompetent patients and 19 patients were immunocompromised. A diagnosis of pulmonary cryptococcosis was based on cytological examination, culture for Cryptococcus neoformans, histopathologic examination, and clinical response to antifungal therapy. All patients underwent chest ultrasound and ultrasound-guided percutaneous transthoracic needle aspiration to obtain specimens for cryptococcal antigen determination. The presence of cryptococcal antigen was determined by the latex agglutination system (CALAS; Meridian Diagnostics, Cincinnati, Ohio). An antigen titer equal to or greater than 1:8 was considered positive. The specimens were also sent for cytological examination, fungal culture, and/or histopathologic examination. A final diagnosis of pulmonary cryptococcosis was made in eight patients. Direct determinations of cryptococcal antigen in lung aspirate were positive in all eight patients with pulmonary cryptococcosis (100% sensitivity, 97% specificity, a positive predictive value of 89%, and negative value of 100%), and there was only one false-positive in noncryptococcosis patients. The diagnostic accuracy was 97.5%. Serum cryptococcal antigen was positive in only three patients with pulmonary cryptococcosis (sensitivity, 37.5%). This study showed that direct measurement of cryptococcal antigen in lung aspirate can be a rapid and useful test for diagnosis of pulmonary cryptococcosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650192      PMCID: PMC228221          DOI: 10.1128/jcm.33.6.1588-1591.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Cryptococcal interstitial pneumonia: value of antigen determination.

Authors:  B D Fisher; D Armstrong
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

2.  Prognostic factors in cryptococcal meningitis. A study in 111 cases.

Authors:  R D Diamond; J E Bennett
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

3.  Pulmonary cryptococcosis.

Authors:  J Gordonson; W Birnbaum; G Jacobson; E N Sargent
Journal:  Radiology       Date:  1974-09       Impact factor: 11.105

4.  The wide spectrum of cryptococcal infections.

Authors:  J L Lewis; S Rabinovich
Journal:  Am J Med       Date:  1972-09       Impact factor: 4.965

5.  Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen.

Authors:  J S Goodman; L Kaufman; M G Koenig
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

6.  Cytologic diagnosis of pulmonary cryptococcosis in immunocompetent hosts.

Authors:  C Y Hsu
Journal:  Acta Cytol       Date:  1993 Sep-Oct       Impact factor: 2.319

7.  The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors.

Authors:  T M Kerkering; R J Duma; S Shadomy
Journal:  Ann Intern Med       Date:  1981-05       Impact factor: 25.391

8.  Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract.

Authors:  R Duperval; P E Hermans; N S Brewer; G D Roberts
Journal:  Chest       Date:  1977-07       Impact factor: 9.410

9.  Diagnosis of pulmonary cryptococcosis by ultrasound guided percutaneous aspiration.

Authors:  L N Lee; P C Yang; S H Kuo; K T Luh; D B Chang; C J Yu
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

10.  Pleural effusions due to Cryptococcus neoformans: a review of the literature and report of two cases with cryptococcal antigen determinations.

Authors:  E J Young; D D Hirsh; V Fainstein; T W Williams
Journal:  Am Rev Respir Dis       Date:  1980-04
View more
  7 in total

1.  Utility of routine testing of bronchoalveolar lavage fluid for cryptococcal antigen.

Authors:  S M Kralovic; J C Rhodes
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

2.  Unique subsite specificity and potential natural function of a chitosan deacetylase from the human pathogen Cryptococcus neoformans.

Authors:  Lea Hembach; Martin Bonin; Christian Gorzelanny; Bruno M Moerschbacher
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-03       Impact factor: 11.205

3.  A rapid urease test for presumptive identification of Cryptococcus neoformans.

Authors:  C E Canteros; L Rodero; M C Rivas; G Davel
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

Review 4.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Cryptococcal antigen testing of lung tissue homogenate improves pulmonary cryptococcosis diagnosis: Two case reports.

Authors:  Wei-Yi Wang; Yu-Lu Zheng; Li-Bin Jiang
Journal:  World J Clin Cases       Date:  2022-04-26       Impact factor: 1.534

6.  Clinical utility of cryptococcal antigen detection in transthoracic needle aspirate by lateral flow assay for diagnosing non-HIV pulmonary cryptococcosis: A multicenter retrospective study.

Authors:  Qun Hu; Xiaohua Li; Xiao Zhou; Chunlei Zhao; Caixia Zheng; Liyu Xu; Zizi Zhou
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

7.  Abdominal Lymphonodular Cryptococcosis in an Immunocompetent Child.

Authors:  Mehjabeen Zaidi; Sonia Qureshi; Sadia Shakoor; Saira Fatima; Fatima Mir
Journal:  Case Rep Pediatr       Date:  2015-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.